Consiglio Nazionale delle Ricerche Contact: Daniele Catalucci (Coordinator) The National Research Council of Italy (CNR) is the largest Italian public research organization, counting 109 institutes and more than 6000 researchers. Its mission is to carry out, promote, spread, transfer and improve research activities in the main sectors of knowledge and their applications for the scientific, technological, economic and social development. Three different institutes of CNR are involved in CUPIDO: IRGB (Institute of Genetic and Biomedical Research - UOS Milan), as coordinator, supported by ISTEC (Institute of Science and Technology for Ceramics) and IEIIT (Institute of Electronics, Computer and Telecommunication Engineering).  Charité - Universitätsmedizin Berlin Contact: Heiner Post In addition to its role in research and teaching, the Charité University Medicine Berlin fundamental mission also includes the care and treatment of patients. With 660,000 outpatient cases and approximately 140,000 inpatient cases a year, Charité treats more patients than any other university hospital in Germany. The Department of Cardiology at the Charité Campus Virchow-Klinikum provides top-level clinical care, large-scale patient studies in a dedicated clinical research unit and a specific focus on translational small and large animal models of cardiac disease. Charité provides a large animal core facility including a high-tech hybrid operating room. Simula Research Laboratory AS Contact: Kristian Valen-Sendstad Dedicated to tackling scientific challenges with long-term impact and of genuine importance to real life, Simula Research Laboratory (SIM) offers an environment that emphasizes and promotes basic research. Simula is also involved in research education and application-driven innovation and commercialization. The laboratory is an internationally leading research institution within select fields in information and communications technology (ICT). These fields are communication systems; scientific computing, aiming at fast and reliable solutions of mathematical models in biomedicine; and software engineering. BIOEMTECH Contact: George Loudos BIOEMTECH Solutions is a fast-growing Greek SME which aims to bridge the gap between ex vivo studies and in vivo molecular imaging by providing cost-effective solutions in terms of instrumentation and services. The company mainly designs and develops low-cost molecular imaging systems and provides imaging services and consultancy with an emphasis on nuclear medicine technology. BIOEMTECH has recently extended its portfolio of imaging by developing an X-ray system and it is in close contact with different end users to achieve the optimal balance between cost and performance. INsrl Contact: Maria Parco IN SRL is an agency founded in 2008 whose mission is to support private and public organizations in participating in EU, national and local innovation projects and to provide professional project management services. IN is currently involved in several collaborations with SMEs, universities and research institutes from all over Europe, mainly in the nanotechnology, chemical, and biomedical sector. IN has supported the development of several SMEs from the set-up to the startup stage within the framework of EU-funded projects and offers a wide range of training services in soft skills, project management, and project financing. Nemera Contact: Raphaele Audibert With over 1,600 people and 4 plants across two continents, Nemera is a world leader in the design, development, and manufacturing of drug delivery solutions. Nemera's expertise covers multiple modes of delivery such as ENT (pumps and valves), ophthalmic (conservative-free eye droppers), parenteral (injectors, insulin pen, safety devices), pulmonary (inhalers), dermal (airless devices). All types of business model can also be proposed from full solution development to pure contract manufacturing, through customized solutions. Over 60 engineers and experts work to innovate for patients at the Innovation Center at La Verpillière near Lyon, France. Imperial College of Science, Technology and Medicine Contact: Terry Tetley Imperial College London is a world leading science-based university and the National Heart and Lung Institute (a Department within the Faculty of Medicine) has a long-standing track record in cardiorespiratory research and contributes more than 50% of the United Kingdom’s publications in leading journals on respiratory research. The Institute embraces innovations in biotechnology and systems biology and seeks to make these accessible at all levels of research. At the same time, the Institute provides integrated structures for translating basic research into new therapies and fosters innovative and ambitious clinical research programs. Cambridge Innovation Technologies Consulting Ltd Contact: Luigi Occhipinti CITC (Cambridge Innovation Technologies Consulting Ltd) is an SME based in Cambridge (UK) with the mission to provide innovation in high-tech fields that require multidisciplinary approaches and know-how: from bio-electronics, integrated smart sensors, and systems to advanced medical solutions. CITC develops partnership programs, helps its customers optimizing their products supply chain, and managing a broad and unique portfolio of technologies. CITC develops feasibility studies and business innovation in emerging medical fields, working with an experienced team of expert engineers, medical advisors, biologists, material scientists and project managers. Sanofi Contact: Didier Bazile Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Consumer Healthcare. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). FIN-CERAMICA Faenza S.p.A. Contact: Claudio De Luca Established in 1992 as a spin-off from the Institute of Science and Technology for Ceramics, Finceramica is now a company that develops, produces and markets innovative therapeutic solutions in the biomedical field. Finceramica is part of Tampieri Group, a consolidated multidisciplinary and dynamic enterprise that understands how to orientate its investments and activities in several strategic business areas. Finceramica’s research activities rotate around human beings and their necessities, as patients and as surgeons, finding innovative biomedical solutions for repair and regeneration of connectives following structural damages, aging and degenerative diseases. L.I.F.E. Italia Contact: Alessandra Leonardi L.I.F.E. is a high-tech company founded in 2011 to create, design, produce and sell intelligent wear. The company has developed specific technologies in advanced fabrics, electronics, conductive materials, sensors, algorithms, communication devices and innovative consumer interfaces. L.I.F.E. has developed important expertise and know-how in telecommunication technologies interfacing hardware and cloud environment (user centric), as well as in designing state-of-the-art data analysis algorithms that together build an innovative platform that brings the concept of telemedicine and telemonitoring to a new level. PlumeStars s.r.l. Contact: Paolo Colombo PlumeStars s.r.l. is an innovative start-up stemming from a project carried out at University of Parma, specialized in drug delivery to lung for the treatment of respiratory diseases. PlumeStar was established in September 2013 out of a patented technology claiming the molecular deposition of fatty acids on drug microparticles to improve their aerodynamic behavior in view of the aerosol administration. The first product on pipeline has been a novel highly respirable amikacin powder to be administered by inhalation with a dry powder inhaler for topical treatment of lung bacterial infections. The powder has remarkable respirability and high drug content. |
